Literature DB >> 27168034

Delivery systems of ceramide in targeted cancer therapy: ceramide alone or in combination with other anti-tumor agents.

Ying-Yu Ma1,2, Xiao-Zhou Mou1, Ya-Hui Ding3, Hai Zou3, Dong-Sheng Huang1,4.   

Abstract

INTRODUCTION: Ceramide is a bioactive lipid which functions as a tumor suppressor, regulating processes such as cell proliferation, differentiation, senescence and apoptosis. However, several challenges need to be overcome in order to realize the therapeutic potential of such a bioactive lipid combination regimen, including the hydrophobic and hemolytic nature of the lipids. AREAS COVERED: In this review, we briefly describe the biological function of ceramide, then the delivery systems that have been developed to improve the pharmacology of ceramide have been summarized. In addition, combination therapies based on these delivery systems to reveal the interactions between therapeutic drugs and ceramide were also highlighted. Furthermore, future perspective before the extension of ceramide's applications in cancer treatment will also be discussed. EXPERT OPINION: Although ceramide has attracted tremendous attention in targeted cancer treatment, its levels are usually suppressed by over-expression of ceramide-metabolizing enzymes or down-regulation of ceramide-generating enzymes. Thus, finding ways to increase ceramide by exogenous treatment in cancer cells is desired. Therefore, translating these bioactive lipids into clinical usage requires a variety of methods, and appropriately designed delivery systems may play the direct and important role in this process.

Entities:  

Keywords:  Ceramide; anti-tumor agents; delivery systems; nanocarrier; targeted therapy

Mesh:

Substances:

Year:  2016        PMID: 27168034     DOI: 10.1080/17425247.2016.1188803

Source DB:  PubMed          Journal:  Expert Opin Drug Deliv        ISSN: 1742-5247            Impact factor:   6.648


  4 in total

Review 1.  Novel Sphingolipid-Based Cancer Therapeutics in the Personalized Medicine Era.

Authors:  Jeremy Shaw; Pedro Costa-Pinheiro; Logan Patterson; Kelly Drews; Sarah Spiegel; Mark Kester
Journal:  Adv Cancer Res       Date:  2018-06-19       Impact factor: 6.242

2.  Ceramide lipid-based nanosuspension for enhanced delivery of docetaxel with synergistic antitumor efficiency.

Authors:  Tianqi Wang; Lixia Feng; Shaomei Yang; Yongjun Liu; Na Zhang
Journal:  Drug Deliv       Date:  2017-11       Impact factor: 6.419

Review 3.  Unique Roles of Sphingolipids in Selected Malignant and Nonmalignant Lesions of Female Reproductive System.

Authors:  Paweł Knapp; Karolina Chomicz; Magdalena Świderska; Adrian Chabowski; Robert Jach
Journal:  Biomed Res Int       Date:  2019-05-02       Impact factor: 3.411

Review 4.  Cell surface sphingomyelin: key role in cancer initiation, progression, and immune evasion.

Authors:  Hatem Tallima; Hassan M E Azzazy; Rashika El Ridi
Journal:  Lipids Health Dis       Date:  2021-10-31       Impact factor: 3.876

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.